ArticleResearch square2024

A Phase I Study of sequences of the CDK4/6 Inhibitor, Ribociclib Combined with Gemcitabine in Patients with Advanced Solid Tumors.

Mahesh Seetharam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.